Polycystic Ovary Syndrome and the Risk of Eclampsia and Maternal Cognitive Impairment: A Population-Based Cohort Study

Ira Febri Yani; Irmiya Rachmiyani; Yudhisman Imran; Triasti Khusfiani; Dina Putri Nasution; Emad Yousif

doi:10.71197/jsocmed.v5i5.302

Polycystic Ovary Syndrome and the Risk of Eclampsia and Maternal Cognitive Impairment: A Population-Based Cohort Study

Ira Febri Yani
Department of Obstetrics and Gynecology, Hermina Tangerang Hospital, Tangerang, Banten, Indonesia.
Irmiya Rachmiyani
Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Trisakti, Jakarta, Indonesia
Yudhisman Imran
Department of Neurology, Faculty of Medicine, Universitas Trisakti, Jakarta, Indonesia
Triasti Khusfiani
Department of Pharmacology, Faculty of Medicine, Universitas Trisakti, Jakarta, Indonesia
Dina Putri Nasution
Department of Otorhinolaryngology–Head and Neck Surgery, Faculty of Medicine, Universitas Trisakti, Jakarta, Indonesia
Emad Yousif
Department of Chemistry, College of Science, Al-Nahrain University , Baghdad, Iraq

Abstract

Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine-metabolic disorder associated with insulin resistance, chronic inflammation, and endothelial dysfunction in women. These abnormalities may increase the risk of hypertensive disorders during pregnancy and subsequent neurological complications. This study evaluated the association between PCOS, eclampsia, and cognitive impairment in women.

Methods: We conducted a narrative review and integrative analysis of studies retrieved from PubMed, Scopus, and Web of Science. Observational studies, clinical investigations, and mechanistic research examining polycystic ovary syndrome, hypertensive disorders of pregnancy, neurological complications, and cognitive outcomes were qualitatively synthesized in this review.

Results: Women with PCOS exhibited a higher risk of gestational hypertension, preeclampsia, and eclampsia than those without PCOS. Insulin resistance, obesity, chronic inflammation, oxidative stress, and endothelial dysfunction are major contributors to vascular and placental abnormalities. Severe hypertensive disorders during pregnancy are also associated with impaired memory, executive dysfunction, reduced attention, and cerebrovascular injury. Shared inflammatory and vascular pathways may explain the relationship between PCOS, eclampsia, and cognitive impairments.

Conclusion: PCOS may be an important risk factor for eclampsia and subsequent cognitive impairment through interconnected metabolic, inflammatory, and endothelial pathways. Early identification and multidisciplinary management may reduce maternal complications and improve long-term neurological outcomes.

Similar Articles

Dian Primadia Putri, Rahmad Isnanta Sembiring, Tambar Kembaren, Putri Eyanoer, Relationship of D-dimer Value to Mortality in Covid-19 Patients with Acute Coronary Syndrome at Haji Adam Malik Hospital Medan , Journal of Society Medicine: Vol. 2 No. 4 (2023): April
Agus Prima , Bastian Lubis , Adjunctive Micronutrient Therapy in Sepsis: Associations with Inflammation and Organ Dysfunction , Journal of Society Medicine: Vol. 5 No. 1 (2026): January
Fentti selli Kurnia, Tresna Kusumah Natapraja, Epidural Anesthesia with Eissenmenger Syndrome Undergoing Caesarean Section : a Case Report , Journal of Society Medicine: Vol. 3 No. 11 (2024): November
Cindy Giovanni, Nurita Dian Kestriani Saragi Sitio, Role of Intravenous Immunoglobulin (IVIG) in Patients with Guillain Barre Syndrome with Severe Community Pneumonia in The Intensive Care Unit (ICU) , Journal of Society Medicine: Vol. 3 No. 3 (2024): March
Anan Chaiyasit, Siriporn Wattanakul , Kittisak Rattanapong , Gut Microbiota as a Critical Modulator of Host Immune Responses in Severe Infections: Mechanistic Insights and Therapeutic Implications , Journal of Society Medicine: Vol. 5 No. 3 (2026): March
Yeni Puspawani, Gusbakti Rusip, Ali Napiah, Curcumin in Sepsis: Anti-Inflammatory Mechanisms, Nano-Formulations, and Evidence from Preclinical and Early Clinical Studies , Journal of Society Medicine: Vol. 5 No. 5 (2026): May
Rachmad Try Hendro, Osmond Muftilov Pison, Management of Acute Respiratory Distress Syndrome Due to Transfusion-Related Acute Lung Injury and Pulmonary Contusion in a Patient with Moderate Head Injury Post-Craniotomy Decompression, Epidural Hematoma, and Posterolateral Rib Fractures 2-6 , Journal of Society Medicine: Vol. 4 No. 7 (2025): July
Yunita Dewani, Gusbakti Rusip , Boyke Marthin Simbolon, Flavonoids in Sepsis: Mechanistic Modulation of Inflammatory Pathways and Therapeutic Potential-A Systematic Review of Preclinical Studies , Journal of Society Medicine: Vol. 5 No. 5 (2026): May
Bernadeth Bernadeth, Muchammad Erias Erlangga, Management of a Critically Ill Post-Cesarean Section Patient with Antepartum Hemorrhage Due to Placenta Previa Totalis in a G2P1A0 at 27–28 Weeks Gestation with Severe Preeclampsia, HELLP Syndrome, Pulmonary Edema, Stage 2 Acute Kidney Injury, and Hypoalbuminemia , Journal of Society Medicine: Vol. 4 No. 7 (2025): July
Diana Fitria Ningsih, Indriasari Indriasari, Management of Acute Hypercapnic Respiratory Failure (AHRF) in Patients with Obesity Hypoventilation Syndrome (OHS) in the Intensive Care Unit (ICU) , Journal of Society Medicine: Vol. 4 No. 7 (2025): July

<< < 1 2 3 4 5 6 7 > >>

You may also start an advanced similarity search for this article.

PDF

Published at

31. May 2026
https://doi.org/10.71197/jsocmed.v5i5.302
Issue:

Vol. 5 No. 5 (2026): May
Section:

Original Research
Keywords:

Polycystic Ovary Syndrome Eclampsia Cognitive Impairment Endothelial Dysfunction Neuroinflammation
References:

Azziz R, Carmina E, Chen Z, Dunaif A, Laven JSE, Legro RS, et al. Polycystic ovary syndrome. Nat Rev Dis Primers. 2016;2:16057.

Teede HJ, Misso ML, Costello MF, Dokras A, Laven J, Moran L, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2018;33(9):18-1602.

Escobar-Morreale HF. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):84-270.

Riestenberg C, Jagasia A, Markovic D, Buyalos RP, Azziz R. Cardiometabolic risk and pregnancy outcomes in women with polycystic ovary syndrome. Fertil Steril. 2022;117(1):31-123.

Palomba S, de Wilde MA, Falbo A, Koster MP, La Sala GB, Fauser BC. Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update. 2015;21(5):92-575.

Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia. Eur J Epidemiol. 2013;28(1):1-19.

Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376(9741):44-631.

Brueckmann M, Seelbach-Göbel B, Engelhorn T. Neurological complications in eclampsia and preeclampsia. Clin Neuroradiol. 2018;28(1):1-9.

Sprung VS, Atkinson G, Cuthbertson DJ, Pugh CJ, Aziz N, Green DJ, et al. Endothelial function measured using flow-mediated dilation in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2013;19(5):92-482.

Basit S, Wohlfahrt J, Boyd HA. Pre-eclampsia and risk of dementia later in life. BMJ. 2018;363.

Dumesic DA, Oberfield SE, Stener-Victorin E, Marshall JC, Laven JSE, Legro RS. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):487-525.

Dokras A. Cardiovascular disease risk in women with PCOS. Steroids. 2013;78(8):6-773.

Lim SS, Kakoly NS, Tan JWJ, Fitzgerald G, Bahri Khomami M, Joham AE, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev. 2019;20(2):53-339.

González F. Inflammation in polycystic ovary syndrome: underpinning of insulin resistance and ovarian dysfunction. Steroids. 2012;77(4):5-300.

Victor VM, Rocha M, Bañuls C, Alvarez A, de Pablo C, Sanchez-Serrano M, et al. Oxidative stress, endothelial dysfunction and atherosclerosis in polycystic ovary syndrome. Curr Pharm Des. 2011;17(26):76-2759.

Phipps EA, Thadhani R, Benzing T, Karumanchi SA. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. 2019;15(5):89-275.

Kjerulff LE, Sanchez-Ramos L, Duffy D. Pregnancy outcomes in women with polycystic ovary syndrome: a meta-analysis. Am J Obstet Gynecol. 2011;204(6):558.e1-6.

Boomsma CM, Eijkemans MJC, Hughes EG, Visser GHA, Fauser BCJM, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(6):83-673.

Escobar-Morreale HF, Luque-Ramírez M, González F. Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and meta-analysis. Fertil Steril. 2011;95(3):58-1048.

Fields JA, Garovic VD, Mielke MM, Kantarci K, Jayachandran M, White WM, et al. Preeclampsia and cognitive impairment later in life. Am J Obstet Gynecol. 2017;217(1):74.e1-11.

Mielke MM, Milic NM, Weissgerber TL, White WM, Kantarci K, Mosley TH, et al. Impaired cognition and brain atrophy decades after hypertensive pregnancy disorders. Circ Cardiovasc Qual Outcomes. 2016;9(1).

Miller EC. Maternal stroke associated with preeclampsia and eclampsia. Curr Hypertens Rep. 2019;21(10):83.

Greenwood EA, Pasch LA, Cedars MI, Legro RS, Eisenberg E, Huddleston HG. Insulin resistance, inflammation, and cognitive function in women with polycystic ovary syndrome. Fertil Steril. 2018;110(4).

Moran LJ, Norman RJ. The impact of obesity on female reproductive function. Hum Reprod Update. 2012;18(5):99-487.
Share:

Z

Yani, I. F., Rachmiyani, I., Imran, Y., Khusfiani, T., Nasution, D. P., & Yousif, E. (2026). Polycystic Ovary Syndrome and the Risk of Eclampsia and Maternal Cognitive Impairment: A Population-Based Cohort Study. Journal of Society Medicine, 5(5), 194–199. https://doi.org/10.71197/jsocmed.v5i5.302